Skip to content

OMDA OMDA Stock-Based Comp

Stock-Based Comp at other companies

Teladoc Health logo
Teladoc HealthTDOC
$14.61M-41.9%
Viking Therapeutics logo
Viking TherapeuticsVKTX
$10.34M-8.9%
Tandem Diabetes Care logo
Tandem Diabetes CareTNDM
$15.66M-38.6%
Insulet logo
InsuletPODD
$21.3M+17.0%
AdaptHealth logo
AdaptHealthAHCO
$6.53M+23.3%
Eli Lilly logo
Eli LillyLLY
$161M+4.5%

Other financials

Income statement

See full
Revenue$78.0M+42.0%
Gross profit$48.7M+52.6%
Operating income-$4.8M+43.1%
Net income-$3.0M+68.6%
EPS (diluted)-$0.05+95.7%

Balance sheet

See full
Cash & equivalents$211.8M+257%
Total debt$30.0M
Total equity$234.1M+160%
Total assets$302.8M

Cash flow

See full
Operating cash flow-$11.8M+26.6%
CapEx$78.0K-75.2%
Free cash flow-$11.9M+27.5%

Valuation

See full
Market cap$1.11B+23.8%
P/S3.9×-0.4×

Profitability

See full
Gross margin66.3%+4.4pp
Operating margin-9.6%-4.0pp
Net margin-11.3%-4.6pp
FCF margin-40.8%

Returns & leverage

See full
Return on equity26.8%
Debt / equity0.1×
Current ratio3.9×

Where this comes from

Reported directly by OMDA in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: OMDA’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about OMDA's stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is OMDA's stock-based comp?
OMDA (OMDA) reported stock-based comp of $4.21M in Q1 2026.
How has OMDA's stock-based comp changed year-over-year?
OMDA's stock-based comp increased by 48.0% year-over-year, from $2.84M to $4.21M.
What does stock-based comp mean?
Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.